A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

NCT06394804 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Low-Grade Serous Ovarian Cancer

Interventions

DRUG: Avutometinib
DRUG: Defactinib
DRUG: Letrozole

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]